1-1 of 1
Xiaopeng Ma
Close
Sort by
Journal Articles

Biomarker Analysis of Zanubrutinib and Tislelizumab Combination Therapy in Patients with Relapsed/Refractory B-Cell Malignancies

Jiaoyan Lyu, Xiaopeng Ma, Ruiqi Huang, Liyun Zhao, Yiling Yu, Oscar Puig, Yang Liu, James Hilger
Journal: Blood
Blood (2022) 140 (Supplement 1): 3521–3522.
https://doi.org/10.1182/blood-2022-168474
Published: 2022